-
EP3797764
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3797764
| EP3797764 - PHARMACOLOGICAL COMPOSITION FOR TREATMENT OF NERVOUS TISSUE DYSFUNCTION, IN PARTICULAR VIRAL LATENCY, AND THE USE OF J05 ATC GROUP SUBSTANCES IN TREATMENT OF NERVOUS TISSUE DYSFUNCTION, IN PARTICULAR VIRAL LATENCY [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 28.04.2023 Database last updated on 27.07.2024 | |
| Former | Examination is in progress Status updated on 25.08.2022 | ||
| Former | Request for examination was made Status updated on 01.10.2021 | ||
| Former | The application has been published Status updated on 26.02.2021 | Most recent event Tooltip | 28.04.2023 | Application deemed to be withdrawn | published on 31.05.2023 [2023/22] | Applicant(s) | For all designated states Janusz Chupty Contissi Ul. Rzeszowska 44 39-200 Debica / PL | [2021/13] | Inventor(s) | 01 /
Chuptys, Piotr ul. Wyspianskiego 2 39-200 Debica / PL | [2021/13] | Representative(s) | Warzybok, Tadeusz Biuro Patentowe "INICJATOR" Sp.z o.o. ul. Zolkiewskiego 7B/1 35-203 Rzeszow / PL | [2021/13] | Application number, filing date | 19460051.6 | 27.09.2019 | [2021/13] | Filing language | PL | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3797764 | Date: | 31.03.2021 | Language: | EN | [2021/13] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 09.03.2020 | Classification | IPC: | A61K31/133, A61K31/19, A61K9/00 | [2021/13] | CPC: |
A61P31/22 (EP);
A61K31/133 (EP);
A61K31/196 (EP);
A61K31/197 (EP);
A61K31/708 (EP);
A61K9/0053 (EP);
| C-Set: |
A61K31/133, A61K2300/00 (EP);
A61K31/196, A61K2300/00 (EP);
A61K31/197, A61K2300/00 (EP);
A61K31/708, A61K2300/00 (EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/44] |
| Former [2021/13] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | PHARMAKOLOGISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG VON DYSFUNKTION DES NERVENGEWEBES, INSBESONDERE DER VIRALEN LATENZ, UND DIE VERWENDUNG VON SUBSTANZEN DER GRUPPE J05 ATC ZUR BEHANDLUNG VON DYSFUNKTION DES NERVENGEWEBES, INSBESONDERE DER VIRALEN LATENZ | [2021/13] | English: | PHARMACOLOGICAL COMPOSITION FOR TREATMENT OF NERVOUS TISSUE DYSFUNCTION, IN PARTICULAR VIRAL LATENCY, AND THE USE OF J05 ATC GROUP SUBSTANCES IN TREATMENT OF NERVOUS TISSUE DYSFUNCTION, IN PARTICULAR VIRAL LATENCY | [2021/13] | French: | COMPOSITION PHARMACOLOGIQUE POUR LE TRAITEMENT DU DYSFONCTIONNEMENT DES TISSUS NERVEUX, EN PARTICULIER LA LATENCE VIRALE, ET UTILISATION DE SUBSTANCES DU GROUPE J05 ATC POUR LE TRAITEMENT DU DYSFONCTIONNEMENT DES TISSUS NERVEUX, EN PARTICULIER LA LATENCE VIRALE | [2021/13] | Examination procedure | 10.02.2021 | Amendment by applicant (claims and/or description) | 24.09.2021 | Examination requested [2021/44] | 24.09.2021 | Date on which the examining division has become responsible | 24.08.2022 | Despatch of a communication from the examining division (Time limit: M04) | 04.01.2023 | Application deemed to be withdrawn, date of legal effect [2023/22] | 25.01.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2023/22] | Fees paid | Renewal fee | 24.09.2021 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 30.09.2022 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]WO9505179 (WELLCOME FOUND [GB], et al) [X] 1-3,6-10 * page 2, lines 1-3;; examples 1-4; claims 1-4 * [I] 4,5; | [XI] - ITO M ET AL, "Chronic mumps virus encephalitis", PEDIATRIC NEUROLOGY, ELSEVIER SCIENCE, NL, vol. 7, no. 6, doi:10.1016/0887-8994(91)90033-H, ISSN 0887-8994, (19911101), pages 467 - 470, (19911101), XP024397990 [X] 1-3,5-10 * figure 2; page 469, right column * [I] 4 DOI: http://dx.doi.org/10.1016/0887-8994(91)90033-H | by applicant | EP1466606 | - DARIUSZ MISZCZAKANNA SLORISKAANNA - GOLKEJOANNA CYMERYS, "Strategie przetrwania herpeswirusow - latencja i apoptoza", Postepy Hig Dosw, (20130000), vol. 67, no. 276, page 287 | - HALCZUK I., "Postqpy w leczeniu padaczki", Neurol Prakt, (20150000), vol. 3, no. 84, pages 5 - 11 |